Poster Presentation
Title : Progressive Steno-Occlusive Syndrome: Moyamoya Disease
Title : Progressive Steno-Occlusive Syndrome: Moyamoya Disease
Presenter
: Ulviyya Gasimova, USA
Abstract :
Introduction : Moyamoya
is a rare disease with reported incidence of 0.086 per 100,000 population Moyamoya disease is deemed a
progressive steno-occlusive disease at terminal portions of the bilateral
internal carotid arteries with the development of “moyamoya vessels” as
collateral channels of circulation .
Case
Report : A 50 year-old white Caucasian male with
known history of diabetes mellitus, hypertension, hyperlipidemia and severe,
multiple vascular
diseases in the setting of moyamoya disease. In 2009, the patient developed
stroke
in territory of right MCA and thoracic spinal
cord infarction which rendered him with residual left-sided numbness, left
lower extremity weakness. The patient also has a history of severe right
carotid stenosis
and multiple TIAs. In July 2016, the patient presented with worsening lower
extremity weakness and incontinence. A diagnosis of Transverse Myelitis
was made. After five days course of IV Solu-Medrol, the patient’s symptoms
improved.
On June 2016, a CT angiogram head with
contrast showed stenosis within the right intracranial internal carotid artery
with chronic occlusion of the M1 segment. A collateralized flow was visualized
as well. A CT angiogram of the neck revealed a plaque and calcification at the right
carotid bulb with resultant marked narrowing (>90% occlusion) in the
proximal right Internal Carotid Artery with resultant pinpoint flow in the
occluded area. Moreover, an atherosclerotic plaque and calcification were seen
in the left carotid bulb with approximately 50-69% stenosis in the proximal
left Internal Carotid Artery.
A MRI for the brain was also done which
showed, in addition to the aforementioned findings, multiple chronic infarcts
within the right MCA- ACA and MCA-PCA watershed distributions. These findings
were the same when compared to radiological studies done in 2011.
No comments:
Post a Comment